查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
DNA 修復药物市场与 COVID-19 影响分析，按药物类型、按应用、按分销渠道、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1339881

DNA 修復药物市场与 COVID-19 影响分析，按药物类型、按应用、按分销渠道、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

DNA Repair Drugs Market with COVID-19 Impact Analysis, By Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 300 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年 DNA 修復药物市场规模为 60.052 亿美元，2023 年至 2030 年復合年增长率为 12.8%。

DNA 修復药物市场-市场动态：

  • 不断增加的癌症病例和不断增长的医疗基础设施刺激了市场需求。
  • 全球癌症病例不断增加，极大提高了开发 DNA 损伤反应药物以解决癌症未满足需求的需求。这些药物在提供特异性且有效耐受的治疗方法以提高癌症生存率方面具有迄今为止闻所未闻的潜力。此外，DNA 修復药物经常与个性化医疗的理念联繫在一起，即根据患者的基因组成和特定突变提供个性化的医疗护理。因此，药物可以针对选择性基因谱进行设计；因此，这一趋势有助于扩大这些药物的潜在市场。然而，对于市场参与者来说，获得 DNA 修復药物的监管批准可能是一个耗时且复杂的过程，可能会限制全球市场的增长。此外，新兴国家不断增加的医疗保健支出和不断发展的医疗保健基础设施为 DNA 修復药物製造商提供了巨大的增长机会。此外，这些地区对有效治疗的需求未得到满足，而且庞大的患者群体创造了有利的市场环境，预计这将促进 DNA 修復市场的增长。

DNA 修復药物市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，全球 DNA 修復药物市场预计在预测期内（2023-2030 年）每年将以 12.8% 左右的复合年增长率增长
  • 由于人口中多种癌症的发病率和患病率不断上升，DNA修復药物行业预计将以显着的速度增长，从而增加了需求
  • 根据药物类型细分，预计 PARP 抑製剂将在不久的将来显示出最大的市场份额
  • 从应用细分来看，心血管疾病是2022年的主导类型
  • 按地区划分，北美是预测期内的主要收入来源

DNA 修復药物市场-細項分析：

  • 全球DNA修復药物市场根据药物类型、应用、分销渠道和地区进行细分。
  • 市场根据药物类型分为三类：烷化剂、PARP抑製剂、拓扑异构酶抑製剂等。 PARP 抑製剂领域可能会占据市场份额。使用 PARP 抑製剂来靶向同源重组修復 (HRR) 途径、广泛存在于转移性前列腺癌和三阴性乳腺癌中的肿瘤，预计将扩大市场规模。此外，在患有 BRCA1/2 突变和 HRR 缺陷的癌症患者中使用 PARP 抑製剂（包括奥拉帕尼、尼拉帕尼和 rucaparib）预计将增强该细分市场的价值。
  • 该市场根据应用分为四类：神经退行性疾病、肿瘤、心血管疾病和中风。心血管疾病领域预计将在预测期内保持其主导地位。 DNA 修復药物具有治疗帕金森病和阿尔茨海默病等多种心血管疾病的潜力。此外，DNA修復可以提供治疗选择。
  • 根据分销渠道，市场分为两类：零售药房、医院药房和其他。医院药房业务增长迅速。该细分市场的增长归因于癌症患病率的上升。此外，这些药物的具体性质及其潜在的副作用，可能需要监测、仔细处理和管理，因此，这些因素可能会推动医院药房部门的增长。

DNA 修復药物市场 - 地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

DNA修復药物市场-竞争格局：

由于主要参与者的存在，DNA 修復药物市场在全球范围内高度集中。此外，不同的製造商在各自的地区占有主要份额。由于癌症患病率的增加，发达市场和新兴市场对技术先进产品的需求有所增加。市场参与者采取的增长战略可能会推动全球市场。据此，这些战略包括併购、创新产品发布、研发活动和合作伙伴关係。例如，2022 年 3 月，佛罗里达州立大学医学院的研究人员做出了一项发现，改变了我们对人体 DNA 修復过程如何运作的理解，并可能导致癌症和其他疾病的新化疗疗法。

最近的发展：

此外，2023 年2 月，Artios Pharma Limited (Artios) 在正在进行的1/2 期试验中引入了随机、2 期扩展队列，评估其共济失调毛细血管扩张和Rad3 相关（“ATR”）抑製剂ART0380，用于治疗与吉西他滨联合治疗铂耐药性卵巢癌。

该研究的主要特点：

  • 这项拟议的 DNA 修復药物市场研究提供了市场规模（百万美元）、年复合成长率（CAGR %）和预测估计（2023-2030 年），以 2022 年为基准年。
  • 该报告为客户提供有关 DNA 修復药物市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了 DNA 修復药物市场有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会、老牌参与者面临的挑战以及 DNA 修復药物市场维持的增长因素。
  • COVID-19 对 DNA 修復药物市场规模、预测、复合年增长率和市场动态的影响将在研究范围下详细讨论。还将详细介绍新冠疫情后 DNA 修復药物市场的情况。
  • 为了让本报告的用户全面了解 DNA 修復药物市场，我们还对 DNA 修復药物市场的竞争格局和关键创新者进行了分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这些参与者将帮助用户了解 DNA 修復药物市场参与者的财务信息和战略倡议。
  • 此外，报告还揭示了全球和区域市场主要参与者的重要收购和兼併、合作和合资、新产品推出、研发、区域扩张。
  • 全球 DNA 修復药物市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师。

目录

第一章：DNA 修復药物市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • DNA 修復药物市场片段（按药物类型）
    • DNA 修復药物市场片段（按应用）
    • DNA 修復药物市场片段（按分销渠道）
    • DNA 修復药物市场片段（按国家/地区）
    • 按地区分類的 DNA 修復药物市场片段
  • 竞争洞察

第 3 章：DNA 修復药物主要市场趋势

  • DNA修復药物市场驱动因素
    • 市场驱动因素的影响分析
  • DNA修復药物市场限制
    • 市场限制影响分析
  • DNA修復药物市场机会
  • DNA修復药物市场未来趋势

第 4 章：DNA 修復药物行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：DNA 修復药物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：DNA 修復药物市场格局

  • 2022 年 DNA 修復药物市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：DNA 修復药物市场 - 按药物类型

  • 概述
    • 按药物类型分類的细分市场份额分析
    • 烷基化剂
    • PARP抑製剂
    • 拓扑异构酶抑製剂
    • 其他

第 8 章：DNA 修復药物市场 -按应用

  • 概述
    • 按应用的细分市场份额分析
    • 神经退行性疾病
    • 肿瘤学
    • 心血管疾病
    • 中风

第 9 章：DNA 修復药物市场 - 按分销渠道

  • 概述
    • 按分销渠道分類的细分市场份额分析
    • 零售药店
    • 医院药房
    • 其他的

第 10 章：DNA 修復药物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • DNA修復药物北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按药物类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按分销渠道）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • DNA修復药物欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按药物类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按分销渠道）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • DNA修復药物亚太地区主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按药物类型）
    • 亚太地区市场规模和预测（按应用）
    • 亚太地区市场规模和预测（按分销渠道）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • DNA 修復药物拉丁美洲主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按药物类型）
    • 拉丁美洲市场规模和预测（按应用）
    • 拉丁美洲市场规模和预测（按分销渠道）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • DNA修復药物中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按药物类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按分销渠道）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - DNA 修復药物行业

  • 竞争仪表板
  • 公司简介
    • Johnson & Johnson
    • Merck Kgaa
    • GlaxoSmithKline plc
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Abbvie Inc.
    • Pfizer Inc.
    • Amgen Inc.
    • Astrazeneca plc
    • Bristol-Myers Squibb Co.
    • Sanofi SA
    • Bayer AG
    • Eli Lilly
    • Gilead Sciences Inc.
    • Merck & Co. Inc.
    • Novartis AG

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1605

REPORT HIGHLIGHT

DNA repair drugs market size was valued at USD 6,005.2 Million in 2022, expanding at a CAGR of 12.8% from 2023 to 2030.

DNA repair drugs are defined as a class of pharmaceuticals that purpose to restore DNA functionality and integrity by helping to repair damaged DNA molecules. Moreover, these drugs are targeting particular DNA repair pathways and assist to restore DNA integrity as well as preventing the progression and development of several diseases, including cancer. The DNA repair drugs market is likely to witness significant growth due to increasing advancements and research activities in the field of molecular and genomics biology.

DNA Repair Drugs Market- Market Dynamics:

  • Increasing cases of cancer and growing healthcare infrastructure to fuel the market demand.
  • The increasing cases of cancer across the world have significantly raised the requirement for developing DNA damage response drugs for solving cancer unmet needs. These medications have hitherto unheard-of potential in providing a specific and effectively tolerated therapy method for boosting cancer survival rates. Moreover, DNA repair drugs are frequently associated with the idea of personalized medicine, where medical care is individualized based on a patient's genetic makeup as well as particular mutations. Thus, the drugs can be designed for selective genetic profiles; as a result, this trend helps to boost the potential market for these drugs. However, for market players, procuring regulatory approvals for DNA repair drugs could be a time-consuming and complex process that may restrain the market growth globally. Furthermore, the increasing healthcare expenditure and growing healthcare infrastructure in the emerging nation offer significant growth opportunities for DNA repair drug manufacturers. Additionally, these regions have an unmet need for effective treatments and a huge patient population creating a favorable market environment, which is projected to boost the DNA repair market growth.

DNA Repair Drugs Market- Key Insights:

  • As per the analysis shared by our research analyst, the global DNA repair drugs market is estimated to grow annually at a CAGR of around 12.8% over the forecast period (2023-2030)
  • The DNA repair drugs industry is projected to grow at a significant rate due to the rising incidence and prevalence of several cancers among the population increase the demand
  • Based on drug type segmentation, PARP inhibitors was predicted to show maximum market share in the near future
  • Based on application segmentation, cardiovascular diseases was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator during the forecast period

DNA Repair Drugs Market- Segmentation Analysis:

  • The global DNA repair drugs market is segmented on the basis of drug type, application, distribution channel, and region.
  • The market is divided into three categories based on drug type: alkylating agents, PARP inhibitors, topoisomerase inhibitors, and others. The PARP inhibitors segment is likely to possess the market share. The use of PARP inhibitors to target homologous recombination repair (HRR) pathways, tumors extensively in metastatic prostate cancer, and triple-negative breast cancer is expected to augment the market size over. Additionally, the utilization of PARP inhibitors including olaparib, niraparib, and rucaparib, in cancer patients with BRCA1/2 mutation and deficiency in HRR is projected to strengthen the segment value.
  • The market is divided into four categories based on application: neurodegenerative diseases, oncological, cardiovascular diseases, and stroke. The cardiovascular diseases segment is expected to maintain its dominance over the forecast period. DNA repair drugs have the potential in treating numerous types of cardiovascular diseases like Parkinson's and Alzheimer's. Moreover, therapeutic options could be provided by DNA repair.
  • The market is divided into two categories based on distribution channels: retail pharmacies, hospital pharmacies, and others. The hospital pharmacies segment is accounted to witness speedy growth. The segment growth is attributed due to the rising prevalence of cancer. Moreover, the specific nature of these drugs and their potential side effects, are likely to require monitoring, careful handling, and administration, as a result, such factors may propel the hospital pharmacies segment growth.

DNA Repair Drugs Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

DNA Repair Drugs Market- Competitive Landscape:

The DNA repair drugs market is highly concentrated across the globe owing to the presence of key players. Additionally, various manufacturers hold a major share in their respective regions. Demand for technologically advanced products has increased in developed as well as emerging markets, due to the increase in the prevalence of cancer. Growth strategies adopted by market players are likely to drive the global market. In line with this, the strategies include mergers & acquisitions, innovative product launches, R&D activities, and partnerships. For instance, in March 2022, a Florida State University College of Medicine researcher made a discovery that alters our understanding of how the body's DNA repair process works and may lead to new chemotherapy treatments for cancer and other diseases.

Recent Developments:

Furthermore, in February 2023, Artios Pharma Limited (Artios) introduced the initiation of a randomized, Phase 2 expansion cohort in the ongoing Phase 1/2 trial evaluating its ataxia telangiectasia and Rad3-related ("ATR") Inhibitor, ART0380, for the treatment of platinum-resistant ovarian cancer in combination with gemcitabine.

Key features of the study:

  • This proposed research study on DNA repair drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the DNA repair drugs market..
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for DNA repair drugs market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the DNA repair drugs market.
  • Impact of COVID-19 on DNA repair drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on DNA repair drugs market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the DNA repair drugs market, we have also included competitive landscape and key innovator analysis for the DNA repair drugs market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the DNA repair drugs market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global DNA repair drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DNA REPAIR DRUGS MARKET KEY PLAYERS

  • Johnson & Johnson
  • Merck Kgaa
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Abbvie Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Astrazeneca plc
  • Bristol-Myers Squibb Co.
  • Sanofi S.A.
  • Bayer AG
  • Eli Lilly
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Novartis AG

GLOBAL DNA REPAIR DRUGS MARKET, BY DRUG TYPE

  • Alkylating Agents
  • PARP Inhibitors
  • Topoisomerase Inhibitors
  • Other

GLOBAL DNA REPAIR DRUGS MARKET, BY APPLICATION

  • Neurodegenerative Diseases
  • Oncological
  • Cardiovascular Diseases
  • Stroke

GLOBAL DNA REPAIR DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

GLOBAL DNA REPAIR DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. DNA Repair Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. DNA Repair Drugs Market Snippet by Drug Type
    • 2.1.2. DNA Repair Drugs Market Snippet by Application
    • 2.1.3. DNA Repair Drugs Market Snippet by Distribution Channel
    • 2.1.4. DNA Repair Drugs Market Snippet by Country
    • 2.1.5. DNA Repair Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. DNA Repair Drugs Key Market Trends

  • 3.1. DNA Repair Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. DNA Repair Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. DNA Repair Drugs Market Opportunities
  • 3.4. DNA Repair Drugs Market Future Trends

4. DNA Repair Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. DNA Repair Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. DNA Repair Drugs Market Landscape

  • 6.1. DNA Repair Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. DNA Repair Drugs Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022&2030 (%)
    • 7.1.2. Alkylating Agents
    • 7.1.3. PARP Inhibitors
    • 7.1.4. Topoisomerase Inhibitors
    • 7.1.5. Other

8. DNA Repair Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Neurodegenerative Diseases
    • 8.1.3. Oncological
    • 8.1.4. Cardiovascular Diseases
    • 8.1.5. Stroke

9. DNA Repair Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
    • 9.1.2. Retail Pharmacies
    • 9.1.3. Hospital Pharmacies
    • 9.1.4. Others

10. DNA Repair Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. DNA Repair Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. DNA Repair Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. DNA Repair Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. DNA Repair Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. DNA Repair Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- DNA Repair Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson
    • 11.2.2. Merck Kgaa
    • 11.2.3. GlaxoSmithKline plc
    • 11.2.4. Abbott Laboratories
    • 11.2.5. F. Hoffmann-La Roche Ltd.
    • 11.2.6. Abbvie Inc.
    • 11.2.7. Pfizer Inc.
    • 11.2.8. Amgen Inc.
    • 11.2.9. Astrazeneca plc
    • 11.2.10. Bristol-Myers Squibb Co.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. Bayer AG
    • 11.2.13. Eli Lilly
    • 11.2.14. Gilead Sciences Inc.
    • 11.2.15. Merck & Co. Inc.
    • 11.2.16. Novartis AG

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE DNA Repair Drugs Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global DNA Repair Drugs Market, by Drug Type2018-2030 (USD Million)
  • TABLE DNA Repair Drugs Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global DNA Repair Drugs Market, by Application2018-2030 (USD Million)
  • TABLE DNA Repair Drugs Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global DNA Repair Drugs Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE DNA Repair Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global DNA Repair Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE EuropeDNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE DNA Repair Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Type segment market share analysis, 2022&2030
  • FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022&2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Europe DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Latin America DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa DNA Repair Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE Germany DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE India DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE Brazil DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)